Rapid Genomic Identification of Pathogens
Detection of biomarkers in tissue and blood
Detection of diverse targets in complex media including clinical samples
UCF researchers have engineered a nanotechnology-based assay that can detect Mycobacterium. In vitro studies demonstrated that the nano-based assays, better known as hybridizing magnetic relaxation nanosensors (hMRS), could specifically detect a conserved genomic element in MycobacteriumΓÇÖs genome, and not DNA from distant or related microorganisms. Hence, this innovative assay provides faster (1 hour v. 12 weeks) and more accurate results, while using less expensive, yet more robust, reagents. This hMRS assay is a deployable diagnostic methodology that is independent of the sampleΓÇÖs optical properties and is suitable for point-of-care screening.
美國
